Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target involves the use of serine protease inhibitors to suppress proinflammatory cytokine production. Serine proteases play a crucial role in various physiological processes, including inflammation. By inhibiting these enzymes, it is possible to reduce the levels of proinflammatory cytokines, which are key mediators of inflammation. This approach is being explored for therapeutic applications in conditions like inflammatory bowel disease and cardiovascular diseases. The mechanism typically involves irreversible inhibition of serine proteases, which disrupts their catalytic activity and prevents further inflammation.
Inhibition of serine proteases to reduce proinflammatory cytokine production, preventing hydrolysis of acyl-enzyme intermediates
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease inhibitors for proinflammatory cytokine suppression.